BTIG has appointed Mikhail Keyserman, CMT, CFTe, has a Managing Director in the firm’s Healthcare Investment Banking division.
In his new role as MD and biotechnology specialist, Keyserman will focus on identifying investment banking and capital markets opportunities across the biotech industry. He will be based out of the firm’s New York office and report directly to KC Stone, Managing Director, Head of BTIG Healthcare Investment Banking.
Prior to his new role with the firm, Keyserman served as a Managing Director and Senior Healthcare Strategy and Franchise Sales Specialist at BTIG.
